Eli LIlly cancer drug is approved in the US
Submitted by ipsita on Sun, 1997-12-28 10:30
The US Food and Drug administration gave approval to Eli Lilly & Co.'s Gerzar anti-cancer compound for first-line therapy against non-small-cell lung cancer, a potentially significant development
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
28/12/1997